Mayur Anand Sirdesai
About Mayur Anand Sirdesai
Data last updated:
Mayur Anand Sirdesai is a Director at Globela Pharma Private Limited (since 2021), Director at Emil Pharmaceutical Industries Private Limited (since 2023) and Nominee Director at Cyrix Healthcare Private Limited (since 2024), and holds 5 more current directorships. The companies operate in Pharma, Healthcare and Professional Services. The 5 current companies with reported revenue have a combined latest revenue of ₹764 Cr; the largest is Globela Pharma Private Limited at ₹296 Cr (FY 2025). Earlier, Mayur Anand Sirdesai was a Director at Iit Bombay Alumni Association (2018–2024) and Nominee Director at Hexagon Nutrition Limited (2016–2024) and 11 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Globela Pharma Private Limited U24230GJ2006PTC047699 | Director | 23 Sep 2021 | 2006 | ₹296 Cr (FY 2025) | Active |
 Emil Pharmaceutical Industries Private Limited U24230MH1986PTC039809 | Director | 17 Apr 2023 | 1986 | ₹233 Cr (FY 2025) | Active |
 Cyrix Healthcare Private Limited U74140KL2013PTC034081 | Nominee Director | 06 Dec 2024 | 2013 | ₹225 Cr (FY 2025) | Active |
 Somerset Healthcare Investment Advisors Private Limited U85100MH2014PTC413209 | Director | 19 Apr 2016 | 2014 | ₹10.34 Cr (FY 2025) | Active |
 Foundation For Cfhe U74999TG2016NPL111348 | Director | 01 Sep 2022 | 2016 | ₹52.2 Lakh (FY 2025) | Active |
| Somerset Health Capital Advisors Private Limited U74999MH2011PTC214291 | Director | 02 Mar 2011 | 2011 | Active | |
| Sicp Investment Advisors India Llp ACB-7399 | Designated Partner | 27 Jun 2023 | 2023 | Active | |
| Somerset Healthcare Investment Advisors Iii Private Limited U85300MH2022PTC395762 | Director | 21 Dec 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Iit Bombay Alumni Association U91120MH2001NPL132741 | Director | 25 Aug 2018 | 2001 | ₹1.45 Cr (FY 2024) | Active |
 Hexagon Nutrition Limited U24110MH1993PLC072189 | Nominee Director | 26 Nov 2016 | 1993 | ₹331 Cr (FY 2025) | Active |
 Browndove Healthcare Private Limited U85144KA2000PTC027601 | Director | 02 Dec 2015 | 2000 | ₹38.41 Cr (FY 2025) | Active |
 Cygnus Medicare Private Limited U85190DL2011PTC391657 | Director | 26 Feb 2013 | 2011 | ₹706 Cr (FY 2025) | Active |
 Prognosys Healthcare (India) Private Limited U74900KA2015PTC079050 | Director | 08 Jul 2015 | 2015 | ₹4.01 Cr (FY 2025) | Active |
 Chayagraphics Healthcare Private Limited U33110KA2014PTC073511 | Director | 21 Aug 2015 | 2014 | ₹15.14 Cr (FY 2025) | Active |
 Prognosys Medical Systems Private Limited U72900KA2003PTC032831 | Director | 03 Mar 2014 | 2003 | ₹70.66 Cr (FY 2025) | Active |
 Altius Healthcare Private Limited U85110DL2008PTC174556 | Director | 26 Feb 2013 | 2008 | ₹67.73 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mayur Anand Sirdesai
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mayur Anand Sirdesai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mayur Anand Sirdesai
Mayur Anand Sirdesai currently holds 8 directorships: Globela Pharma Private Limited (Director, since 23 Sep 2021, revenue ₹296 Cr (FY 2025)); Emil Pharmaceutical Industries Private Limited (Director, since 17 Apr 2023, revenue ₹233 Cr (FY 2025)); Cyrix Healthcare Private Limited (Nominee Director, since 06 Dec 2024, revenue ₹225 Cr (FY 2025)); Somerset Healthcare Investment Advisors Private Limited (Director, since 19 Apr 2016, revenue ₹10.34 Cr (FY 2025)); Foundation For Cfhe (Director, since 01 Sep 2022, revenue ₹52.2 Lakh (FY 2025)); and 3 more.
Mayur Anand Sirdesai was first appointed on 15 Dec 2009 as Director at Lexicon Lifesciences Private Limited. The most recent appointment on record is 06 Dec 2024 at Cyrix Healthcare Private Limited.
The 5 current companies of Mayur Anand Sirdesai that report revenue have a combined latest revenue of ₹764 Cr: Globela Pharma Private Limited ₹296 Cr (FY 2025); Emil Pharmaceutical Industries Private Limited ₹233 Cr (FY 2025); Cyrix Healthcare Private Limited ₹225 Cr (FY 2025); Somerset Healthcare Investment Advisors Private Limited ₹10.34 Cr (FY 2025); Foundation For Cfhe ₹52.2 Lakh (FY 2025).
Mayur Anand Sirdesai held 13 earlier board appointments: Iit Bombay Alumni Association (Director, 25 Aug 2018 to 26 Aug 2024); Hexagon Nutrition Limited (Nominee Director, 26 Nov 2016 to 12 Jun 2024); Browndove Healthcare Private Limited (Director, 02 Dec 2015 to 25 Apr 2024); Cygnus Medicare Private Limited (Director, 26 Feb 2013 to 02 Apr 2024); Prognosys Healthcare (India) Private Limited (Director, 08 Jul 2015 to 27 Jul 2023); and 8 more.
The current boards of Mayur Anand Sirdesai's companies include Bhanubhai Shambhubhai Vaghashia (Globela Pharma Private Limited), Pietro Ermanno Stefanutti (Globela Pharma Private Limited), Priyank Vaghashia (Globela Pharma Private Limited), Tony Girishkumar Gandhi (Globela Pharma Private Limited), Urmilaben Bhanubhai Vaghasiya (Globela Pharma Private Limited), Abhijit Rajendra Gole (Emil Pharmaceutical Industries Private Limited), among others.